$CAH

Cardinal Health To Buy AdaptHealth's Diabetes Unit, Strive Medical For $360 Mln Total

Cardinal Health (CAH) agreed to buy AdaptHealth’s Diabetes Health unit (AHCO) and Strive Medical for about $360 million in cash, subject to working capital adjustments. The deals are expected to be accretive to non-GAAP EPS in the first 12 months after closing, pending regulatory approvals. Diabetes Health serves 225,000+ people annually; Strive Medical serves 20,000+.

Original reporting
Published Jul 21, 2026, 5:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 5:50 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cardinal Health To Buy AdaptHealth's Diabetes Unit, Strive Medical For $360 Mln Total — source image
Decision brief

The 30-second read

$CAHBullishMed
01

Why it matters

The disclosed tuck-in acquisitions expand CAH’s diabetes management and urology-related home medical supply footprint, with deal economics framed as accretive and dependent on regulatory approvals.

02

Market read

Traders can reassess CAH’s M&A-driven growth outlook and near-term risk around closing conditions and integration, using the disclosed deal size and accretion claim.

03

What to watch

Working-capital adjustments and customary closing conditions are unspecified; deal timing and final economics could differ from the headline $360M.

Relevance 8/10Novelty 8/10Timing: deal announced late Monday, with after-hours/overnight trading context

Background

CAH is pursuing growth in its at-Home Solutions business and cites synergies from its prior acquisition of Advanced Diabetes Supply.

Company-level read

Ticker impact

$CAHBullishMedium confidence
Context

Cardinal Health agreed to buy AdaptHealth’s Diabetes Health unit and Strive Medical for about $360M cash, subject to approvals.

Expected impact

Likely modest positive bias around deal headlines, then volatility tied to regulatory/closing conditions and integration expectations.

Evidence & confidence

The article discloses a new acquisition agreement with deal value, cash consideration, accretion claim, and regulatory closing conditions, which are actionable for positioning.

Market effects

Reinforces consolidation in home medical supplies and diabetes management, potentially increasing competitive pressure on other at-home solution providers.

No specific regional impact disclosed.

Primarily US-focused home-care and medical supply operations; limited global read-through from the text.

Counterpoint

Accretion to non-GAAP EPS in the first 12 months may be optimistic; integration costs, reimbursement dynamics, and regulatory delays could dilute the near-term benefit.

Key entities

  • Cardinal Health, Inc.

    Buyer of AdaptHealth’s Diabetes Health unit and Strive Medical for about $360M cash.

  • AdaptHealth Corp.

    Seller of the Diabetes Health business unit to Cardinal Health.

  • Strive Medical

    Urology-focused home medical supply provider being acquired by Cardinal Health.

  • Advanced Diabetes Supply

    Prior acquisition cited by CAH as the basis for synergies.

Related articles

$CAHMedAI 8/10

Cardinal Health makes acquisition duo worth $360m for home care business advance

Cardinal Health said it will buy Strive Medical and AdaptHealth’s diabetes business in a combined $360m deal to expand its at-home solutions. The company noted prior diabetes acquisition of Advanced Diabetes Supply in April 2025 and recent urology buys. Cardinal cited operational progress since ADS closing, including migrating volume, adding about 500,000 customers, and launching ContinuCare Pathway.

$CAHMedAI 9/10

Cardinal Health to buy AdaptHealth diabetes unit, Strive Medical for $360 million By Reuters

Cardinal Health (CAH) agreed to buy AdaptHealth’s diabetes health business for $235 million cash and to acquire Strive Medical in a separate deal, for about $360 million total, to expand its at-Home Solutions and diabetes care. Cardinal said the deals should add to adjusted EPS within 12 months after closing. AdaptHealth and Strive Medical described their diabetes and urology-focused services.

$CAHMedAI 8/10

Cardinal Health expands home care business with two tuck-in acquisitions

Cardinal Health (NYSE: CAH) said it agreed to buy AdaptHealth’s Diabetes Health business and acquire Strive Medical, expanding its at-Home Solutions unit. The deals total about $360 million in cash, subject to working capital adjustments, and are expected to be accretive to non-GAAP EPS in the first 12 months after closing. Closing depends on regulatory approvals.

$METAMed

It's a jam-packed afternoon of developments impacting 7 portfolio stocks

CNBC’s Investing Club said stocks rose Thursday as investors discounted U.S.-Iran escalation. Meta shares swung after Reuters reported plans to expand AI compute and release Muse Park 1.1 with an API. Cowen raised Cardinal Health’s target to $275. FedEx launched Life Sciences. Reuters said Honeywell may add Europe defense products. Starbucks rose on Bloomberg AI software plans.

$CAHMed

Cardinal Health Stock: Is CAH Outperforming the Healthcare Sector?

Cardinal Health (CAH), a Dublin, Ohio healthcare distributor and solutions provider, reported Q3 fiscal 2026 revenue up 11% to $60.90B and non-GAAP operating earnings up 18% to $956M. Non-GAAP EPS rose 35% to $3.17. The company raised fiscal 2026 non-GAAP EPS guidance to $10.70–$10.80. CAH shares have outperformed peers and analysts rate it “Strong Buy” with a $247.47 mean target.